Hope Medicine reports first patient dosed in Phase III trial of HMI-115
25 March 2026 - Clinical-stage biopharmaceutical company Hope Medicine Inc announced on Tuesday that the first patient has been dosed in the Phase III clinical trial of HMI-115, its first-in-class mon...
M2 Pharma
via M2 Pharma - Corroborated by 6 others
Updated 1h ago
Source Verification
Corroboration Score: 7This story was independently reported by 7 sources. Click any source to read the original article.
Comments
0 commentsBe respectful and constructive.
Loading comments...
Previous
Projections for Every MLB Team's 2026 Opening Day Lineup, Rotation and More
Next
The hidden cost of sperm storage: Ejaculates found to deteriorate across the animal kingdom
Related Articles
ScienceDay 1,491 of WW3: Russian soldier claims that, in retaliation for being conscripted and sent into combat despite being a student, he passed the location of his unit to Ukraine, resulting in 150 KIA. This is your Wednesday Ukraine War thread [News]
The Submitter-1h ago-1 sources
ScienceANALYSIS: Five key takeaways from the 2026 Danish election result
Becky Waterton-1h ago-1 sources
ScienceNational Police Commissioner Fannie Masemola to be charged over ‘Cat’ Matlala’s R360m tender
Jeff Wicks-2h ago-1 sources